Charles N. York II - Jul 1, 2022 Form 4 Insider Report for Day One Biopharmaceuticals, Inc. (DAWN)

Role
COO, CFO and Secretary
Signature
/s/ Charles N. York II
Stock symbol
DAWN
Transactions as of
Jul 1, 2022
Transactions value $
-$45,580
Form type
4
Date filed
7/6/2022, 09:00 PM
Previous filing
Jan 20, 2022
Next filing
Jul 12, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction DAWN Common Stock Sale -$29.6K -1.48K -0.44% $20.00 336K Jul 1, 2022 Direct F1
transaction DAWN Common Stock Sale -$16K -800 -0.24% $20.00 335K Jul 5, 2022 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person.